Psychological effects of hormone replacement therapy: a comparison of tibolone and a sequential estrogen therapy

被引:27
作者
Ross, LA
Alder, EM
Cawood, EHH
Brown, J
Gebbie, AE
机构
[1] Queen Margaret Coll, Edinburgh, Midlothian, Scotland
[2] Edinburgh Healthcare NHS Trust, Family Planning Serv, Edinburgh, Midlothian, Scotland
[3] Edinburgh Healthcare NHS Trust, Well Woman Serv, Edinburgh, Midlothian, Scotland
关键词
psychology; hormone replacement therapy; menopause; estrogen;
D O I
10.3109/01674829909075581
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Hormone replacement therapy (HRT) is effective in alleviating vasomotor symptoms bur the effect on psychological symptoms is less clear: This study aimed to compare the psychological effects of two regimens of HRT in perimenopausal women in a randomized, initially double-blind controlled trial. Thirty-eight women reporting climacteric symptoms were randomly allocated into either oral conjugated quine estrogen 0.625 mg daily plus progestogen (norgestrel) 150 mu g for the last 12 days of each 28 day cycle, or tibolone 2.5 mg/day for 28 days. They were assessed using standardised psychological assessments. There were no significant differences in changes from baseline between the two types of therapy. For both groups combined there were significant improvements compared with baseline in vasomotor symptoms in the first month, plus anxiety, sleep, memory and somatic dysfunction by the second and third months, but not in scores of depression. Log linear analysis of weekly scores showed that depression scores were significantly related to improvement in vasomotor scores independent of type of therapy and time on HRT: Memory problems were related to vasomotor symptoms independent of depression. No difference between the two types of therapy was found, nor any direct effect of HRT on anxiety or depression The results support the domino theory suggesting that psychological improvement follows alleviation of vasomotor symptoms.
引用
收藏
页码:88 / 96
页数:9
相关论文
共 23 条
[1]   The Blatt-Kupperman menopausal index: a critique [J].
Alder, E .
MATURITAS, 1998, 29 (01) :19-24
[2]  
ALDER EM, 1992, J PSYCHOSOM OBST GYN, V13, P23
[3]   RELATION BETWEEN PLASMA-HORMONE PROFILES, SYMPTOMS, AND RESPONSE TO ESTROGEN-TREATMENT IN WOMEN APPROACHING THE MENOPAUSE [J].
CHAKRAVARTI, S ;
COLLINS, WP ;
THOM, MH ;
STUDD, JWW .
BRITISH MEDICAL JOURNAL, 1979, 1 (6169) :983-985
[4]   Well-being and the menopausal transition [J].
Dennerstein, L ;
Dudley, E ;
Burger, H .
JOURNAL OF PSYCHOSOMATIC OBSTETRICS AND GYNECOLOGY, 1997, 18 (02) :95-101
[5]  
DENNERSTEIN L, 1980, OBSTET GYNECOL, V56, P316
[6]   Impact of percutaneous oestradiol gels in postmenopausal hormone replacement therapy on clinical symptoms and endometrium [J].
Foidart, JM ;
Beliard, A ;
Hedon, B ;
Ochsenbein, E ;
Bernard, AM ;
Bergeron, C ;
Thomas, JL .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (03) :305-310
[7]   SYMPTOMS OF ESTROGEN DEFICIENCY ASSOCIATED WITH SUPRAPHYSIOLOGICAL PLASMA ESTRADIOL CONCENTRATIONS IN WOMEN WITH ESTRADIOL IMPLANTS [J].
GANGAR, K ;
CUST, M ;
WHITEHEAD, MI .
BRITISH MEDICAL JOURNAL, 1989, 299 (6699) :601-602
[8]   STEROID REPLACEMENT TREATMENT INCREASES BETA-ENDORPHIN AND BETA-LIPOTROPIN PLASMA-LEVELS IN POSTMENOPAUSAL WOMEN [J].
GENAZZANI, AR ;
PETRAGLIA, F ;
FACCHINETTI, F ;
GRASSO, A ;
ALESSANDRINI, G ;
VOLPE, A .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1988, 26 (02) :153-159
[9]   Transdermal oestrogen for treatment of severe postnatal depression [J].
Gregoire, AJP ;
Kumar, R ;
Everitt, B ;
Henderson, AF ;
Studd, JWW .
LANCET, 1996, 347 (9006) :930-933
[10]   THE WOMENS HEALTH QUESTIONNAIRE - A MEASURE OF MID-AGED WOMENS PERCEPTIONS OF THEIR EMOTIONAL AND PHYSICAL HEALTH [J].
HUNTER, M .
PSYCHOLOGY & HEALTH, 1992, 7 (01) :45-54